 | • レポートコード：QFJ1-5984 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、組換え凝固因子の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（リコンビナントファクターVIII、リコンビナントファクターIX、フォンウィルブランドファクター）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・組換え凝固因子の市場動向 ・企業の競争状況、市場シェア ・組換え凝固因子の種類別市場規模と予測2016-2027（リコンビナントファクターVIII、リコンビナントファクターIX、フォンウィルブランドファクター） ・組換え凝固因子の用途別市場規模と予測2016-2027（病院、クリニック、研究機関） ・組換え凝固因子の北米市場規模2016-2027（アメリカ、カナダ） ・組換え凝固因子の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・組換え凝固因子のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・組換え凝固因子の中南米市場規模2016-2027（メキシコ、ブラジル） ・組換え凝固因子の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Baxter International Inc.、Bayer AG、Biogen Idec、CSL Ltd.、Grifols International SA、Kedrion S.P.A.、Novo Nordisk A/S、Octapharma AG、Pfizer Inc.） ・結論 |
Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.
Market Analysis and Insights: Global Recombinant Coagulation Factors Market
The global Recombinant Coagulation Factors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant Coagulation Factors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant Coagulation Factors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant Coagulation Factors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant Coagulation Factors market.
Global Recombinant Coagulation Factors Scope and Market Size
Recombinant Coagulation Factors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Coagulation Factors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Recombinant Factor VIII
Recombinant Factor IX
Von Willebrand Factor
Segment by Application
Hospitals
Clinics
Research Organizations
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Baxter International Inc.
Bayer AG
Biogen Idec
CSL Ltd.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Coagulation Factors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Recombinant Factor VIII
1.2.3 Recombinant Factor IX
1.2.4 Von Willebrand Factor
1.3 Market by Application
1.3.1 Global Recombinant Coagulation Factors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Organizations
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Coagulation Factors Market Perspective (2016-2027)
2.2 Recombinant Coagulation Factors Growth Trends by Regions
2.2.1 Recombinant Coagulation Factors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant Coagulation Factors Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant Coagulation Factors Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant Coagulation Factors Industry Dynamic
2.3.1 Recombinant Coagulation Factors Market Trends
2.3.2 Recombinant Coagulation Factors Market Drivers
2.3.3 Recombinant Coagulation Factors Market Challenges
2.3.4 Recombinant Coagulation Factors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Coagulation Factors Players by Revenue
3.1.1 Global Top Recombinant Coagulation Factors Players by Revenue (2016-2021)
3.1.2 Global Recombinant Coagulation Factors Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant Coagulation Factors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant Coagulation Factors Revenue
3.4 Global Recombinant Coagulation Factors Market Concentration Ratio
3.4.1 Global Recombinant Coagulation Factors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Coagulation Factors Revenue in 2020
3.5 Recombinant Coagulation Factors Key Players Head office and Area Served
3.6 Key Players Recombinant Coagulation Factors Product Solution and Service
3.7 Date of Enter into Recombinant Coagulation Factors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Coagulation Factors Breakdown Data by Type
4.1 Global Recombinant Coagulation Factors Historic Market Size by Type (2016-2021)
4.2 Global Recombinant Coagulation Factors Forecasted Market Size by Type (2022-2027)
5 Recombinant Coagulation Factors Breakdown Data by Application
5.1 Global Recombinant Coagulation Factors Historic Market Size by Application (2016-2021)
5.2 Global Recombinant Coagulation Factors Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Recombinant Coagulation Factors Market Size (2016-2027)
6.2 North America Recombinant Coagulation Factors Market Size by Type
6.2.1 North America Recombinant Coagulation Factors Market Size by Type (2016-2021)
6.2.2 North America Recombinant Coagulation Factors Market Size by Type (2022-2027)
6.2.3 North America Recombinant Coagulation Factors Market Size by Type (2016-2027)
6.3 North America Recombinant Coagulation Factors Market Size by Application
6.3.1 North America Recombinant Coagulation Factors Market Size by Application (2016-2021)
6.3.2 North America Recombinant Coagulation Factors Market Size by Application (2022-2027)
6.3.3 North America Recombinant Coagulation Factors Market Size by Application (2016-2027)
6.4 North America Recombinant Coagulation Factors Market Size by Country
6.4.1 North America Recombinant Coagulation Factors Market Size by Country (2016-2021)
6.4.2 North America Recombinant Coagulation Factors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Recombinant Coagulation Factors Market Size (2016-2027)
7.2 Europe Recombinant Coagulation Factors Market Size by Type
7.2.1 Europe Recombinant Coagulation Factors Market Size by Type (2016-2021)
7.2.2 Europe Recombinant Coagulation Factors Market Size by Type (2022-2027)
7.2.3 Europe Recombinant Coagulation Factors Market Size by Type (2016-2027)
7.3 Europe Recombinant Coagulation Factors Market Size by Application
7.3.1 Europe Recombinant Coagulation Factors Market Size by Application (2016-2021)
7.3.2 Europe Recombinant Coagulation Factors Market Size by Application (2022-2027)
7.3.3 Europe Recombinant Coagulation Factors Market Size by Application (2016-2027)
7.4 Europe Recombinant Coagulation Factors Market Size by Country
7.4.1 Europe Recombinant Coagulation Factors Market Size by Country (2016-2021)
7.4.2 Europe Recombinant Coagulation Factors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Coagulation Factors Market Size (2016-2027)
8.2 Asia-Pacific Recombinant Coagulation Factors Market Size by Type
8.2.1 Asia-Pacific Recombinant Coagulation Factors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant Coagulation Factors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant Coagulation Factors Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant Coagulation Factors Market Size by Application
8.3.1 Asia-Pacific Recombinant Coagulation Factors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant Coagulation Factors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant Coagulation Factors Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant Coagulation Factors Market Size by Region
8.4.1 Asia-Pacific Recombinant Coagulation Factors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant Coagulation Factors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant Coagulation Factors Market Size (2016-2027)
9.2 Latin America Recombinant Coagulation Factors Market Size by Type
9.2.1 Latin America Recombinant Coagulation Factors Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant Coagulation Factors Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant Coagulation Factors Market Size by Type (2016-2027)
9.3 Latin America Recombinant Coagulation Factors Market Size by Application
9.3.1 Latin America Recombinant Coagulation Factors Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant Coagulation Factors Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant Coagulation Factors Market Size by Application (2016-2027)
9.4 Latin America Recombinant Coagulation Factors Market Size by Country
9.4.1 Latin America Recombinant Coagulation Factors Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant Coagulation Factors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Coagulation Factors Market Size (2016-2027)
10.2 Middle East & Africa Recombinant Coagulation Factors Market Size by Type
10.2.1 Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant Coagulation Factors Market Size by Application
10.3.1 Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant Coagulation Factors Market Size by Country
10.4.1 Middle East & Africa Recombinant Coagulation Factors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant Coagulation Factors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Company Details
11.1.2 Baxter International Inc. Business Overview
11.1.3 Baxter International Inc. Recombinant Coagulation Factors Introduction
11.1.4 Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.1.5 Baxter International Inc. Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Recombinant Coagulation Factors Introduction
11.2.4 Bayer AG Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.2.5 Bayer AG Recent Development
11.3 Biogen Idec
11.3.1 Biogen Idec Company Details
11.3.2 Biogen Idec Business Overview
11.3.3 Biogen Idec Recombinant Coagulation Factors Introduction
11.3.4 Biogen Idec Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.3.5 Biogen Idec Recent Development
11.4 CSL Ltd.
11.4.1 CSL Ltd. Company Details
11.4.2 CSL Ltd. Business Overview
11.4.3 CSL Ltd. Recombinant Coagulation Factors Introduction
11.4.4 CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.4.5 CSL Ltd. Recent Development
11.5 Grifols International SA
11.5.1 Grifols International SA Company Details
11.5.2 Grifols International SA Business Overview
11.5.3 Grifols International SA Recombinant Coagulation Factors Introduction
11.5.4 Grifols International SA Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.5.5 Grifols International SA Recent Development
11.6 Kedrion S.P.A.
11.6.1 Kedrion S.P.A. Company Details
11.6.2 Kedrion S.P.A. Business Overview
11.6.3 Kedrion S.P.A. Recombinant Coagulation Factors Introduction
11.6.4 Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.6.5 Kedrion S.P.A. Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Details
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Recombinant Coagulation Factors Introduction
11.7.4 Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Octapharma AG
11.8.1 Octapharma AG Company Details
11.8.2 Octapharma AG Business Overview
11.8.3 Octapharma AG Recombinant Coagulation Factors Introduction
11.8.4 Octapharma AG Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.8.5 Octapharma AG Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Recombinant Coagulation Factors Introduction
11.9.4 Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2016-2021)
11.9.5 Pfizer Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Recombinant Coagulation Factors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Recombinant Factor VIII
Table 3. Key Players of Recombinant Factor IX
Table 4. Key Players of Von Willebrand Factor
Table 5. Global Recombinant Coagulation Factors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Recombinant Coagulation Factors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Recombinant Coagulation Factors Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Recombinant Coagulation Factors Market Share by Regions (2016-2021)
Table 9. Global Recombinant Coagulation Factors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Recombinant Coagulation Factors Market Share by Regions (2022-2027)
Table 11. Recombinant Coagulation Factors Market Trends
Table 12. Recombinant Coagulation Factors Market Drivers
Table 13. Recombinant Coagulation Factors Market Challenges
Table 14. Recombinant Coagulation Factors Market Restraints
Table 15. Global Recombinant Coagulation Factors Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Recombinant Coagulation Factors Market Share by Players (2016-2021)
Table 17. Global Top Recombinant Coagulation Factors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Coagulation Factors as of 2020)
Table 18. Ranking of Global Top Recombinant Coagulation Factors Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Recombinant Coagulation Factors Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Recombinant Coagulation Factors Product Solution and Service
Table 22. Date of Enter into Recombinant Coagulation Factors Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Recombinant Coagulation Factors Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Recombinant Coagulation Factors Revenue Market Share by Type (2016-2021)
Table 26. Global Recombinant Coagulation Factors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Recombinant Coagulation Factors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Recombinant Coagulation Factors Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Recombinant Coagulation Factors Revenue Market Share by Application (2016-2021)
Table 30. Global Recombinant Coagulation Factors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Recombinant Coagulation Factors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Recombinant Coagulation Factors Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Recombinant Coagulation Factors Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Recombinant Coagulation Factors Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Recombinant Coagulation Factors Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Recombinant Coagulation Factors Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Recombinant Coagulation Factors Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Recombinant Coagulation Factors Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Recombinant Coagulation Factors Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Recombinant Coagulation Factors Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Recombinant Coagulation Factors Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Recombinant Coagulation Factors Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Recombinant Coagulation Factors Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Recombinant Coagulation Factors Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Recombinant Coagulation Factors Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Recombinant Coagulation Factors Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Recombinant Coagulation Factors Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Recombinant Coagulation Factors Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Recombinant Coagulation Factors Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Recombinant Coagulation Factors Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Recombinant Coagulation Factors Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Recombinant Coagulation Factors Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Recombinant Coagulation Factors Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Recombinant Coagulation Factors Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Recombinant Coagulation Factors Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Recombinant Coagulation Factors Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Recombinant Coagulation Factors Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Recombinant Coagulation Factors Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Recombinant Coagulation Factors Market Size by Country (2022-2027) & (US$ Million)
Table 62. Baxter International Inc. Company Details
Table 63. Baxter International Inc. Business Overview
Table 64. Baxter International Inc. Recombinant Coagulation Factors Product
Table 65. Baxter International Inc. Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 66. Baxter International Inc. Recent Development
Table 67. Bayer AG Company Details
Table 68. Bayer AG Business Overview
Table 69. Bayer AG Recombinant Coagulation Factors Product
Table 70. Bayer AG Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 71. Bayer AG Recent Development
Table 72. Biogen Idec Company Details
Table 73. Biogen Idec Business Overview
Table 74. Biogen Idec Recombinant Coagulation Factors Product
Table 75. Biogen Idec Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 76. Biogen Idec Recent Development
Table 77. CSL Ltd. Company Details
Table 78. CSL Ltd. Business Overview
Table 79. CSL Ltd. Recombinant Coagulation Factors Product
Table 80. CSL Ltd. Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 81. CSL Ltd. Recent Development
Table 82. Grifols International SA Company Details
Table 83. Grifols International SA Business Overview
Table 84. Grifols International SA Recombinant Coagulation Factors Product
Table 85. Grifols International SA Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 86. Grifols International SA Recent Development
Table 87. Kedrion S.P.A. Company Details
Table 88. Kedrion S.P.A. Business Overview
Table 89. Kedrion S.P.A. Recombinant Coagulation Factors Product
Table 90. Kedrion S.P.A. Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 91. Kedrion S.P.A. Recent Development
Table 92. Novo Nordisk A/S Company Details
Table 93. Novo Nordisk A/S Business Overview
Table 94. Novo Nordisk A/S Recombinant Coagulation Factors Product
Table 95. Novo Nordisk A/S Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 96. Novo Nordisk A/S Recent Development
Table 97. Octapharma AG Company Details
Table 98. Octapharma AG Business Overview
Table 99. Octapharma AG Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 100. Octapharma AG Recent Development
Table 101. Pfizer Inc. Company Details
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. Recombinant Coagulation Factors Product
Table 104. Pfizer Inc. Revenue in Recombinant Coagulation Factors Business (2016-2021) & (US$ Million)
Table 105. Pfizer Inc. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Coagulation Factors Market Share by Type: 2020 VS 2027
Figure 2. Recombinant Factor VIII Features
Figure 3. Recombinant Factor IX Features
Figure 4. Von Willebrand Factor Features
Figure 5. Global Recombinant Coagulation Factors Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Organizations Case Studies
Figure 9. Recombinant Coagulation Factors Report Years Considered
Figure 10. Global Recombinant Coagulation Factors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Recombinant Coagulation Factors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Recombinant Coagulation Factors Market Share by Regions: 2020 VS 2027
Figure 13. Global Recombinant Coagulation Factors Market Share by Regions (2022-2027)
Figure 14. Global Recombinant Coagulation Factors Market Share by Players in 2020
Figure 15. Global Top Recombinant Coagulation Factors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Coagulation Factors as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Coagulation Factors Revenue in 2020
Figure 17. Global Recombinant Coagulation Factors Revenue Market Share by Type (2016-2021)
Figure 18. Global Recombinant Coagulation Factors Revenue Market Share by Type (2022-2027)
Figure 19. North America Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Recombinant Coagulation Factors Market Share by Type (2016-2027)
Figure 21. North America Recombinant Coagulation Factors Market Share by Application (2016-2027)
Figure 22. North America Recombinant Coagulation Factors Market Share by Country (2016-2027)
Figure 23. United States Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Recombinant Coagulation Factors Market Share by Type (2016-2027)
Figure 27. Europe Recombinant Coagulation Factors Market Share by Application (2016-2027)
Figure 28. Europe Recombinant Coagulation Factors Market Share by Country (2016-2027)
Figure 29. Germany Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Recombinant Coagulation Factors Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Recombinant Coagulation Factors Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Recombinant Coagulation Factors Market Share by Region (2016-2027)
Figure 39. China Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Recombinant Coagulation Factors Market Share by Type (2016-2027)
Figure 47. Latin America Recombinant Coagulation Factors Market Share by Application (2016-2027)
Figure 48. Latin America Recombinant Coagulation Factors Market Share by Country (2016-2027)
Figure 49. Mexico Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Recombinant Coagulation Factors Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Recombinant Coagulation Factors Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Recombinant Coagulation Factors Market Share by Country (2016-2027)
Figure 55. Turkey Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Recombinant Coagulation Factors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Baxter International Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 59. Bayer AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 60. Biogen Idec Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 61. CSL Ltd. Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 62. Grifols International SA Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 63. Kedrion S.P.A. Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 64. Novo Nordisk A/S Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 65. Octapharma AG Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 66. Pfizer Inc. Revenue Growth Rate in Recombinant Coagulation Factors Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
組換え第VIII因子のグローバル市場調査 2019年 The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspecti…- 組換え第VIII因子のグローバル市場調査 2019年 The global Recombinant Factor VIII market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Recombinant Factor VIII volume and value at global level, regional level and company level. From a global perspecti…
- ヒト血液凝固因子VIIのグローバル市場2021 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
- ヒト血液凝固因子VIIIのグローバル市場2021 Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. North America is the largest consumption market of Human Coagulation Factor VIII, with sal…
- 世界の凝固第XI因子市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Coagulation Factor XI Market The global Coagulation Factor XI market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…